PL3394045T3 - Kokryształ, sposób jego wytwarzania i lek zawierający kokryształ - Google Patents

Kokryształ, sposób jego wytwarzania i lek zawierający kokryształ

Info

Publication number
PL3394045T3
PL3394045T3 PL16831645T PL16831645T PL3394045T3 PL 3394045 T3 PL3394045 T3 PL 3394045T3 PL 16831645 T PL16831645 T PL 16831645T PL 16831645 T PL16831645 T PL 16831645T PL 3394045 T3 PL3394045 T3 PL 3394045T3
Authority
PL
Poland
Prior art keywords
cocrystal
production method
medicament containing
medicament
containing cocrystal
Prior art date
Application number
PL16831645T
Other languages
English (en)
Inventor
Koya KIMOTO
Mitsuo Yamamoto
Masato Kitayama
Yasuhiro Sawai
Miyuki Hohokabe
Kentaro IWATA
Original Assignee
Takeda Pharmaceutical Company Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Company Limited filed Critical Takeda Pharmaceutical Company Limited
Publication of PL3394045T3 publication Critical patent/PL3394045T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C55/00—Saturated compounds having more than one carboxyl group bound to acyclic carbon atoms
    • C07C55/02—Dicarboxylic acids
    • C07C55/08—Malonic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13—Dicarboxylic acids
    • C07C57/145—Maleic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235—Saturated compounds containing more than one carboxyl group
    • C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
    • C07C59/265—Citric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/48—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings
    • C07C59/50—Mandelic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/54—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/03—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring
    • C07C65/05—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring o-Hydroxy carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/03—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring
    • C07C65/05—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups monocyclic and having all hydroxy or O-metal groups bound to the ring o-Hydroxy carboxylic acids
    • C07C65/10—Salicylic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL16831645T 2015-12-24 2016-12-22 Kokryształ, sposób jego wytwarzania i lek zawierający kokryształ PL3394045T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2015252658 2015-12-24
PCT/JP2016/089224 WO2017111179A1 (en) 2015-12-24 2016-12-22 Cocrystal, production method thereof, and medicament containing cocrystal
EP16831645.3A EP3394045B1 (en) 2015-12-24 2016-12-22 Cocrystal, production method thereof, and medicament containing cocrystal

Publications (1)

Publication Number Publication Date
PL3394045T3 true PL3394045T3 (pl) 2021-09-27

Family

ID=57910088

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16831645T PL3394045T3 (pl) 2015-12-24 2016-12-22 Kokryształ, sposób jego wytwarzania i lek zawierający kokryształ

Country Status (26)

Country Link
US (1) US10836745B2 (pl)
EP (1) EP3394045B1 (pl)
JP (1) JP6876704B2 (pl)
KR (1) KR102687603B1 (pl)
CN (1) CN108473467B (pl)
AR (1) AR107132A1 (pl)
AU (1) AU2016375899B2 (pl)
CA (1) CA3009610C (pl)
CL (1) CL2018001725A1 (pl)
CO (1) CO2018006473A2 (pl)
DK (1) DK3394045T3 (pl)
EA (1) EA039213B1 (pl)
EC (1) ECSP18055921A (pl)
ES (1) ES2877089T3 (pl)
HK (1) HK1256362A1 (pl)
IL (1) IL260195A (pl)
MX (1) MX380656B (pl)
PE (1) PE20181626A1 (pl)
PH (1) PH12018501356A1 (pl)
PL (1) PL3394045T3 (pl)
SG (1) SG11201805331QA (pl)
TN (1) TN2018000221A1 (pl)
TW (1) TWI722080B (pl)
UY (1) UY37046A (pl)
WO (1) WO2017111179A1 (pl)
ZA (1) ZA201804393B (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019071187A1 (en) 2017-10-06 2019-04-11 Cargill, Incorporated STABILIZED GLYCOSIDE COMPOSITIONS OF STEVIOL AND USES THEREOF
CA3078200C (en) * 2017-10-06 2023-09-19 Cargill, Incorporated Steviol glycoside solubility enhancers
BR112021019948A2 (pt) 2019-04-06 2021-12-14 Cargill Inc Intensificador de solubilidade de glicosídeo de esteviol, solução aquosa de glicosídeo de esteviol, e, bebida não alcoólica
BR112021019811A2 (pt) 2019-04-06 2021-12-07 Cargill Inc Composição de glicosídeo de esteviol, bebida, métodos para reduzir um atributo sensorial indesejável de uma solução aquosa de glicosídeo de esteviol, para reduzir a persistência de doçura de um componente de glicosídeo de esteviol em uma composição comestível e para reduzir o amargor de um componente de glicosídeo de esteviol em uma composição comestível, e, soluções aquosa de glicosídeo de esteviol com reduzida persistência de doçura e aquosa de glicosídeo de esteviol com reduzido amargor
CN110818692B (zh) * 2019-11-08 2023-03-24 中国海洋大学 一种替加氟与丁香酸的共晶及其制备方法
TWI845802B (zh) * 2020-04-21 2024-06-21 健亞生物科技股份有限公司 硫酸羥氯喹之晶體
CN116473975B (zh) * 2023-04-11 2026-03-13 东南大学 奥沙普秦和异烟酰胺或吡嗪酰胺低共熔物、药物组合物及其制备方法
CN117383998B (zh) * 2023-09-28 2026-07-28 天津理工大学 一种共晶的制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
GB9518953D0 (en) 1995-09-15 1995-11-15 Pfizer Ltd Pharmaceutical formulations
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
CO4940418A1 (es) 1997-07-18 2000-07-24 Novartis Ag Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso
JP2001519346A (ja) 1997-10-07 2001-10-23 シェーリング コーポレイション 抗真菌性結晶性多形物
US6608055B2 (en) 2001-06-22 2003-08-19 Boehringer Ingelheim Pharma Kg Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
US6737432B2 (en) 2001-10-31 2004-05-18 Boehringer Ingelheim Pharma Kg Crystalline form of telmisartan sodium
US7927613B2 (en) 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US20090031844A1 (en) 2007-02-28 2009-02-05 Nsk Ltd. Tilt-type steering apparatus
US7741330B1 (en) 2009-10-12 2010-06-22 Pharmacyclics, Inc. Pyrazolo-pyrimidine inhibitors of Bruton's tyrosine kinase
US8883802B2 (en) 2009-12-03 2014-11-11 Astrazeneca Ab Co-crystals of a triazolo [4,5-D] pyrimide platelet aggregation inhibitor
KR20140048968A (ko) 2011-07-13 2014-04-24 파마시클릭스, 인코포레이티드 브루톤형 티로신 키나제의 억제제
JO3377B1 (ar) 2013-03-11 2019-03-13 Takeda Pharmaceuticals Co مشتقات بيريدينيل وبيريدينيل مندمج

Also Published As

Publication number Publication date
UY37046A (es) 2017-07-31
ES2877089T3 (es) 2021-11-16
TN2018000221A1 (en) 2019-10-04
US20170183326A1 (en) 2017-06-29
CA3009610C (en) 2024-02-13
CN108473467B (zh) 2021-08-13
JP2019504025A (ja) 2019-02-14
PE20181626A1 (es) 2018-10-11
EP3394045B1 (en) 2021-05-19
JP6876704B2 (ja) 2021-05-26
MX2018007721A (es) 2018-08-15
KR20180095933A (ko) 2018-08-28
DK3394045T3 (da) 2021-08-16
TWI722080B (zh) 2021-03-21
HK1256362A1 (zh) 2019-09-20
CN108473467A (zh) 2018-08-31
CO2018006473A2 (es) 2018-07-10
AU2016375899B2 (en) 2021-05-13
MX380656B (es) 2025-03-12
ZA201804393B (en) 2019-09-25
EA039213B1 (ru) 2021-12-17
BR112018012915A2 (pt) 2018-12-11
KR102687603B1 (ko) 2024-07-24
EA201891467A1 (ru) 2018-12-28
AU2016375899A1 (en) 2018-07-19
CA3009610A1 (en) 2017-06-29
TW201730181A (zh) 2017-09-01
CL2018001725A1 (es) 2018-10-19
ECSP18055921A (es) 2018-10-31
US10836745B2 (en) 2020-11-17
WO2017111179A1 (en) 2017-06-29
AR107132A1 (es) 2018-03-21
IL260195A (en) 2018-07-31
EP3394045A1 (en) 2018-10-31
PH12018501356A1 (en) 2019-02-18
SG11201805331QA (en) 2018-07-30

Similar Documents

Publication Publication Date Title
HUE057289T2 (hu) Oxopikolinamid-származék, annak elõállítási módszere és gyógyszerészeti felhasználása
ZA201804393B (en) Cocrystal, production method thereof, and medicament containing cocrystal
IL256744A (en) A new derivative of pyrizin, its preparation method and medical application
SG11201709414XA (en) Powdered titanium oxide, method for the production thereof, and use thereof
PL3204207T3 (pl) Sposób dalszego przetwarzania produktu prefabrykowanego i przynależny produkt prefabrykowany
GB201408673D0 (en) Medicaments,uses and methods
PL3309138T3 (pl) Sposób koprodukcji 2,3,3,3-tetrafluoropropylenu i 1,3,3,3-tetrafluoropropylenu
HUE067910T2 (hu) Lényegében diaszereomer-tiszta foszforamidkloridát, eljárás és gyógyszerészeti készítmény
SG11201703631VA (en) Novel carbodiimides, method for the production and use thereof
ZA201802654B (en) Cephem compounds, their production and use
PL3328757T3 (pl) Torebka filtrująca do produktów infuzyjnych i sposób wytwarzania torebki filtrującej
EP3170794A4 (en) Composition including silicotitanate having sitinakite structure, and production method for same
GB2561089B (en) Process for the preparation of 17beta-hydroxy-des-a-androst-9, 10-en-5-one
PT3350150T (pt) 1,1-difeniletilenos substituídos por alcenilfenoxilo, processos para a sua preparação e sua utilização
IL257985B (en) Material, its use and method for producing the material
IL250223A0 (en) A method for the preparation of the pyrimidin-1-ol compound, and its intermediates
GB201517133D0 (en) New pharmaceutical use
EP3263146A4 (en) Method for manufacturing medical material, medical material, and anti-adhesion material
PT3153505T (pt) Novos bis-indolilmetanos, um processo para a sua preparação e utilizações dos mesmos
GB201503211D0 (en) Dental product, use of a dental product and methods of use of a dental product
GB201508609D0 (en) Tracheostomy tube packs, Tube assenblies sets and methods
TWI562978B (en) Method for preparation of 1,4-cyclohexanedialkanol
GB201713386D0 (en) 4-pregnene-16a-methyl-17a-mellow-3, 20-diketone drug synthesis method
GB2542135B (en) A fungicidal composition, method and use of the same
GB201503733D0 (en) New drug application